Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Boehringer bets up to $730M on a new lung cancer drug
Boehringer bets up to $730M on a new lung cancer drug
Boehringer bets up to $730M on a new lung cancer drug
Submitted by
admin
on July 29, 2015 - 9:49pm
Source:
Fierce Biotech
News Tags:
Boehringer Ingelheim
Hanmi Pharmaceutical
lung cancer
HM61713
Headline:
Boehringer bets up to $730M on a new lung cancer drug
Do Not Allow Advertisers to Use My Personal information
